Holder evidence
1
SEC ownership of Axonics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001603756.
Lead holder
Danny L. Dearen
13D/G signal
—
Latest evidence
29 Sep 2023
- CIK
- 0001603756
- Location
- Irvine, CA
- SEC evidence mix
- 3/4/5
- Lead holder
- Danny L. Dearen
- Latest evidence date
- 29 Sep 2023
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Axonics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Danny L. Dearen
13D/G signal
—
Evidence rows
1
Latest as of
29 Sep 2023
3/4/5
Highest disclosed value: $1,640,658
Rank 1 holder
Danny L. Dearen
3/4/5
- Ownership
- —
- Position
- $1.64M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Danny L. Dearen |
3/4/5
President & CFO
|
—
class O/S missing
|
$1,640,658
23,777 shares
|
— | 29 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 30 May 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Current reporting-owner rows connected to Axonics, Inc.. Open the relationship link for the CIK-to-CIK filing trail.
Rows
13
Lead holder
Danny L. Dearen
Net 12M change
$0
Latest report
15 Nov 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Danny L. Dearen | President & CFO | $1,640,658 | Mixed | 29 Sep 2023 | ||
| Ph.D John Woock | EVP, Chief Mktg/Strtgy Officer | $0 | Mixed | 15 Nov 2024 | ||
| Karen Noblett | Chief Medical Officer | $0 | Mixed | 15 Nov 2024 | ||
| Raymond W. Cohen | Chief Executive Officer, Director | $0 | Mixed | 15 Nov 2024 | ||
| Jane E. Kiernan | Director | $0 | Mixed | 15 Nov 2024 | ||
| Michael H. Carrel | Director | $0 | Mixed | 15 Nov 2024 | ||
| David M. Demski | Director | $0 | Mixed | 15 Nov 2024 | ||
| Robert McNamara | Director | $0 | Mixed | 15 Nov 2024 | ||
| Kari Leigh Keese | Chief Financial Officer | $0 | Mixed | 15 Nov 2024 | ||
| Alfred J. Ford Jr. | Chief Commercial Officer | $0 | Mixed | 15 Nov 2024 | ||
| Esteban Lopez | Director | $0 | Mixed | 15 Nov 2024 | ||
| Rinda Sama | Chief Operating Officer | $0 | Mixed | 15 Nov 2024 | ||
| Nancy Lynn Snyderman MD | Director | $0 | Mixed | 15 Nov 2024 |
Recent insider transactions for Axonics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.